Top

International Breastfeeding Journal

Published in:

Open Access 01-03-2007 | Review

A new paradigm for depression in new mothers: the central role of inflammation and how breastfeeding and anti-inflammatory treatments protect maternal mental health

Author: Kathleen Kendall-Tackett

Published in: International Breastfeeding Journal | Issue 1/2007

Abstract

Background

Research in the field of psychoneuroimmunology (PNI) has revealed that depression is associated with inflammation manifested by increased levels of proinflammatory cytokines.

Discussion

The old paradigm described inflammation as simply one of many risk factors for depression. The new paradigm is based on more recent research that has indicated that physical and psychological stressors increase inflammation. These recent studies constitute an important shift in the depression paradigm: inflammation is not simply a risk factor; it is the risk factor that underlies all the others. Moreover, inflammation explains why psychosocial, behavioral and physical risk factors increase the risk of depression. This is true for depression in general and for postpartum depression in particular. Puerperal women are especially vulnerable to these effects because their levels of proinflammatory cytokines significantly increase during the last trimester of pregnancy – a time when they are also at high risk for depression. Moreover, common experiences of new motherhood, such as sleep disturbance, postpartum pain, and past or current psychological trauma, act as stressors that cause proinflammatory cytokine levels to rise. Breastfeeding has a protective effect on maternal mental health because it attenuates stress and modulates the inflammatory response. However, breastfeeding difficulties, such as nipple pain, can increase the risk of depression and must be addressed promptly.

Conclusion

PNI research suggests two goals for the prevention and treatment of postpartum depression: reducing maternal stress and reducing inflammation. Breastfeeding and exercise reduce maternal stress and are protective of maternal mood. In addition, most current treatments for depression are anti-inflammatory. These include long-chain omega-3 fatty acids, cognitive therapy, St. John's wort, and conventional antidepressants.

Available only for authorised users

Kendall-Tackett KA: Depression in New Mothers: Causes, Consequences and Treatment Options. 2005, Binghamton, Haworth Press

Maes M, Lin A-H, Ombelet W, Stevens K, Kenis G, deJongh R, Cox J, Bosmans E: Immune activation in the early puerperium is related to postpartum anxiety and depression symptoms. Psychoneuroendocrinology. 2000, 25: 121-137. 10.1016/S0306-4530(99)00043-8.CrossRefPubMed

Maes M, Bosmans E, Ombelet W: In the puerperium, primiparae exhibit higher levels of anxiety and serum peptidase activity and greater immune responses than multiparae. J Clin Psychiatry. 2004, 65: 71-76.CrossRefPubMed

Coussons-Read ME, Okun ML, Schmitt MP, Giese S: Prenatal stress alters cytokine levels in a manner that may endanger human pregnancy. Psychosom Med. 2005, 67: 625-631. 10.1097/01.psy.0000170331.74960.ad.CrossRefPubMed

Kiecolt-Glaser JK, Belury MA, Porter K, Beversdoft D, Lemeshow S, Glaser R: Depressive symptoms, omega-6: omega-3 fatty acids, and inflammation in older adults. Psychosom Med. 2007,

Robles TF, Glaser R, Kiecolt-Glaser JK: Out of balance: A new look at chronic stress, depression, and immunity. Curr Dir Psych Sci. 2005, 14: 111-115. 10.1111/j.0963-7214.2005.00345.x.CrossRef

Schiepers OJ, Wichers MC, Maes M: Cytokines and major depression. Prog Neuropsychopharmacol Biol Psychiatry. 2005, 29: 201-217. 10.1016/j.pnpbp.2004.11.003.CrossRefPubMed

Groër MW, Davis MW: Cytokines, infections, stress, and dysphoric moods in breastfeeders and formula feeders. J Obstet Gynecol Neonatal Nurs. 2006, 35: 599-607. 10.1111/j.1552-6909.2006.00083.x.CrossRefPubMed

Groër MW, Davis MW, Hemphill J: Postpartum stress: Current concepts and the possible protective role of breastfeeding. J Obstet Gyncol Neonatal Nurs. 2002, 31: 411-417. 10.1111/j.1552-6909.2002.tb00063.x.CrossRef

10.

Groër MW, Morgan K: Immune, health and endocrine characteristics of depressed postpartum mothers. Psychoneuroendocrinology. 2007,

11.

Maes M, Christophe A, Bosmans E, Lin A, Neels H: In humans, serum polyunsaturated fatty acid levels predict the response of proinflammatory cytokines to psychologic stress. Biol Psychiatry. 2000, 47: 910-920. 10.1016/S0006-3223(99)00268-1.CrossRefPubMed

12.

Joynt KE, Whelan DJ, O'Connor CM: Depression and cardiovascular disease: Mechanisms of interaction. Biol Psychiatry. 2003, 54: 248-261. 10.1016/S0006-3223(03)00568-7.CrossRefPubMed

13.

Kop WJ, Gottdiener JS: The role of immune system parameters in the relationship between depression and coronary artery disease. Psychosom Med. 2005, 67: S37-S41. 10.1097/01.psy.0000162256.18710.4a.CrossRefPubMed

14.

Kiecolt-Glaser JK, Glaser R: Depression and immune function: Central pathways to morbidity and mortality. J Psychosom Res. 2002, 53: 873-876. 10.1016/S0022-3999(02)00309-4.CrossRefPubMed

15.

Miller GE, Rohleder N, Stetler C, Kirschbaum C: Clinical depression and regulation of the inflammatory response during acute stress. Psychosom Med. 2005, 67: 679-687. 10.1097/01.psy.0000174172.82428.ce.CrossRefPubMed

16.

Dayan J, Creveuil C, Marks MN, Conroy S, Herlicoviez M, Dreyfus M, Tordjman S: Prenatal depression, prenatal anxiety, and spontaneous preterm birth: A prospective cohort study among women with early and regular care. Psychosom Med. 2006, 68: 938-946. 10.1097/01.psy.0000244025.20549.bd.CrossRefPubMed

17.

Seng JS, Oakley DJ, Sampselle CM, Killion C, Graham-Bermann S, Liberzon I: Posttraumatic stress disorder and pregnancy complications. Obstet Gynecol. 2001, 97: 17-22. 10.1016/S0029-7844(00)01097-8.CrossRefPubMed

18.

Patel V, Prince M: Maternal psychological morbidity and low birth weight in India. Brit J Psychiatry. 2006, 188: 284-285. 10.1192/bjp.bp.105.012096.CrossRef

19.

Smuts CM, Huang M, Mundy D, Plasse T, Major S, Carlson SE: A randomized trial of docosahexaenoic acid supplementation during the third trimester of pregnancy. Obstet Gynecol. 2003, 101: 469-479. 10.1016/S0029-7844(02)02585-1.CrossRefPubMed

20.

McEwen BS: Mood disorders and allostatic load. Biol Psychiatry. 2003, 54: 200-207. 10.1016/S0006-3223(03)00177-X.CrossRefPubMed

21.

Kendall-Tackett KA: Hidden Feelings of Motherhood. 2005, Amarillo, Texas: Hale Publishing, 2

22.

Kendall-Tackett KA: Cardiovascular disease and metabolic syndrome as sequelae of violence against women: A psychoneuroimmunology approach. Trauma Violence Abuse. 2007,

23.

Ross LE, Murray BJ, Steiner M: Sleep and perinatal mood disorders: A critical review. J Psychiatry Neurosci. 2005, 30: 247-256.PubMedCentralPubMed

24.

Konsman JP, Parnet P, Dantzer R: Cytokine-induced sickness behaviour: Mechanisms and implications. Trends Neurosci. 2002, 25: 154-159. 10.1016/S0166-2236(00)02088-9.CrossRefPubMed

25.

Motivala SJ, Safati A, Olmos L, Irwin MR: Inflammatory markers and sleep disturbance in major depression. Psychosom Med. 2005, 67: 187-194. 10.1097/01.psy.0000149259.72488.09.CrossRefPubMed

26.

Corwin EJ, Bozoky I, Pugh LC, Johnston N: Interleukin-1beta elevation during the postpartum period. Ann Behav Med. 2003, 25: 41-47. 10.1207/S15324796ABM2501_06.CrossRefPubMed

27.

Groër M, Davis K, Casey B, Short B, Smith K, Groer S: Neuroendocrine and immune relationships in postpartum fatigue. MCN Am J Matern Child Nurs. 2005, 30: 133-138. 10.1097/00005721-200503000-00012.CrossRefPubMed

28.

Kendall-Tackett KA: Treating the Lifetime Health Effects of Childhood Victimization. 2003, Kingston, Civic Research Institute

29.

Ansara D, Cohen MM, Gallop R, Kung R, Kung R, Schei B: Predictors of women's physical health problems after childbirth. J Psychosom Obstet Gynaecol. 2005, 26: 115-125. 10.1080/01443610400023064.CrossRefPubMed

30.

Geracioti TD, Carpenter LL, Owens MJ, Baker DG, Ekhator NN, Horn PS, Strawn JR, Sanacora G, Kinkead B, Price LH, Nemeroff CB: Elevated cerebrospinal fluid substance P concentrations in posttraumatic stress disorder and major depression. Am J Psychiatry. 2006, 163: 637-643. 10.1176/appi.ajp.163.4.637.CrossRefPubMed

31.

Machelska H, Mousa SA, Stein C: Pain and immune function. Psychoneuroimmunology. Edited by: Ader R, Felten DL, Cohen N. 2001, New York: Academic Press, 2: 111-121. Third

32.

Maier SF, Watkins LR: Cytokines for psychologists: Implications of bidirectional immune-to-brain communication for understanding behavior, mood and cognition. Psychol Rev. 1998, 105: 83-107. 10.1037/0033-295X.105.1.83.CrossRefPubMed

33.

Simopoulos AP: Omega-3 fatty acids in inflammation and autoimmune diseases. J Am Coll Nutr. 2002, 21: 495-505.CrossRefPubMed

34.

Roizenblatt S, Moldofsky H, Benedito-Silva AA, Tufik S: Alpha sleep characteristics in fibromyalgia. Arthritis Rheum. 2001, 44: 222-230. 10.1002/1529-0131(200101)44:1<222::AID-ANR29>3.0.CO;2-K.CrossRefPubMed

35.

McKenna JJ, McDade T: Why babies should never sleep alone: A review of the co-sleeping controversy in relation to SIDS, bedsharing and breast feeding. Paediatr Respir Rev. 2005, 6: 134-152. 10.1016/j.prrv.2005.03.006.CrossRefPubMed

36.

Amir LH, Dennerstein L, Garland SM, Fisher J, Farish SJ: Psychological aspects of nipple pain in lactating women. J Psychosom Obstet Gynaecol. 1996, 17: 53-58.CrossRefPubMed

37.

McGovern P, Dowd B, Gjerdingen D, Gross CR, Kenney S, Ukestad L, McCaffrey D, Lundberg U: Postpartum health of employed mothers 5 weeks after childbirth. Ann Fam Med. 2006, 4: 159-167. 10.1370/afm.519.PubMedCentralCrossRefPubMed

38.

Delahanty DL, Dougall AL, Baum A: Neuroendocrine and immune alterations following natural disasters and traumatic stress. Psychoneuroimmunology. Edited by: Ader R, Felten DL, Cohen N. 2001, New York, Academic Press, 2: 335-345. Third

39.

Kendall-Tackett KA: Physiological correlates of childhood abuse: Chronic hyperarousal in PTSD, depression and irritable bowel syndrome. Child Abuse Negl. 2000, 24: 799-810. 10.1016/S0145-2134(00)00136-8.CrossRefPubMed

40.

Dallam S: Health issues associated with violence against women. Handbook of Women, Stress and Trauma. Edited by: Kendall-Tackett KA. 2005, New York: Taylor & Francis, 159-180.

41.

Baker DG, Ekhator NN, Kasckow JW, Dashevsky B, Horn PS, Bednarik L, Geracioti TD: Higher levels of basal serial CSF cortisol in combat veterans with posttraumatic stress disorder. Am J Psychiatry. 2005, 162: 992-994. 10.1176/appi.ajp.162.5.992.CrossRefPubMed

42.

Elzinga BM, Schmahl CG, Vermetten E, van Dyck R, Bremner JD: Higher cortisol levels following exposure to traumatic reminders in abuse-related PTSD. Neuropsychopharmacology. 2003, 28: 1656-1665. 10.1038/sj.npp.1300226.CrossRefPubMed

43.

American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders, Text Revision. 2000, Washington DC, American Psychiatric Association, 4

44.

Beck CT: Post-traumatic stress disorder due to childbirth: the aftermath. Nurs Res. 2004, 53: 216-224. 10.1097/00006199-200407000-00004.CrossRefPubMed

45.

Galea S, Vlahov D, Resnick H, Ahern J, Susser E, Gold J, Bucuvalas M, Kilpatrick D: Trends of probable post-traumatic stress disorder in New York City after the September 11 terrorist attacks. Am J Epidem. 2003, 158: 514-524. 10.1093/aje/kwg187.CrossRef

46.

Kendall-Tackett KA: Trauma associated with perinatal events: Birth experience, prematurity, and childbearing loss. Handbook of Women, Stress and Trauma. Edited by: Kendall-Tackett KA. 2005, New York, Taylor & Francis, 53-74.

47.

Grajeda R, Perez-Escamilla R: Stress during labor and delivery is associated with delayed onset of lactation among urban Guatemalan women. J Nutr. 2002, 132: 3055-3060.PubMed

48.

Johnson JD, O'Connor KA, Deak T, Spencer RL, Watkins LR, Maier SF: Prior stressor exposure primes the HPA axis. Psychoneuroendocrinology. 2002, 27: 353-365. 10.1016/S0306-4530(01)00057-9.CrossRefPubMed

49.

Mezzacappa ES, Katkin ES: Breast-feeding is associated with reduced perceived stress and negative mood in mothers. Health Psychol. 2002, 21: 187-193. 10.1037/0278-6133.21.2.187.CrossRefPubMed

50.

Groër MW: Differences between exclusive breastfeeders, formula-feeders, and controls: A study of stress, mood, and endocrine variables. Biol Res Nurs. 2005, 7: 106-117. 10.1177/1099800405280936.CrossRefPubMed

51.

Heinrichs M, Meinlschmidt G, Neumann I, Wagner S, Kirschbaum C, Ehlert U, Hellhammer DH: Effects of suckling on hypothalamic-pituitary-adrenal axis responses to psychosocial stress in postpartum lactating women. J Clin Endocrinol Metab. 2001, 86: 4798-4804. 10.1210/jc.86.10.4798.CrossRefPubMed

52.

Groër MW, Davis MW, Smith K, Casey K, Kramer V, Bukovsky E: Immunity, inflammation and infection in post-partum breast and formula feeders. Am J Reprod Immunol. 2005, 54: 222-231. 10.1111/j.1600-0897.2005.00301.x.CrossRefPubMed

53.

Jones NA, McFall BA, Diego MA: Patterns of brain electrical activity in infants of depressed mothers who breastfeed and bottle feed: The mediating role of infant temperament. Biol Psychol. 2004, 67: 103-124. 10.1016/j.biopsycho.2004.03.010.CrossRefPubMed

54.

Hassmen P, Koivula N, Uutela A: Physical exercise and psychological well-being: A population study in Finland. Prev Med. 2000, 30: 17-25. 10.1006/pmed.1999.0597.CrossRefPubMed

55.

Babyak M, Blumenthal JA, Herman S, Khatri P, Doraiswamy M, Moore K, Craighead WE, Baldewicz TT, Krishnan KR: Exercise treatment for major depression: Maintenance of therapeutic benefit at 10 months. Psychosom Med. 2000, 62: 633-638.CrossRefPubMed

56.

Freeman MP, Hibbeln JR, Wisner KL, Davis JM, Mischoulon D, Peet M, Keck PE, Marangell LB, Richardson AJ, Lake J, Stoll AL: Omega-3 fatty acids: Evidence basis for treatment and future research in psychiatry. J Clin Psychiatry. 2006, 67: 1954-1967.CrossRefPubMed

57.

Rees A-M, Austin M-P, Parker G: Role of omega-3 fatty acids as a treatment for depression in the perinatal period. Aust N Z J Psychiatry. 2005, 39: 274-280. 10.1111/j.1440-1614.2005.01565.x.CrossRefPubMed

58.

Bratman S, Girman AM: Handbook of Herbs and Supplements and Their Therapeutic Uses. 2003, St Louis, Mosby

59.

Ferrucci L, Cherubini A, Bandinelli S, Bartali B, Corsi A, Lauretani F, Martin A, Andres-Lacueva C, Senin U, Guralnik JM: Relationship of plasma polyunsaturated fatty acids to circulating inflammatory markers. J Clin Endocrinol Metabol. 2006, 91: 439-446. 10.1210/jc.2005-1303.CrossRef

60.

Tanskanen A, Hibbeln JR, Tuomilehto J, Uutela A, Haukkala A, Viinamaki H, Lehtonen J, Vartiainen E: Fish consumption and depressive symptoms in the general population of Finland. Psychiatr Serv. 2001, 52: 529-531. 10.1176/appi.ps.52.4.529.CrossRefPubMed

61.

Noaghiul S, Hibbeln JR: Cross-national comparisons of seafood consumption and rates of bipolar disorders. Am J Psychiatry. 2003, 160: 2222-2227. 10.1176/appi.ajp.160.12.2222.CrossRefPubMed

62.

Sublette ME, Hibbeln JR, Galfalvy H, Oquendo MA, Mann JJ: Omega-3 polyunsaturated essential fatty acid status as a predictor of future suicide risk. Am J Psychiatry. 2006, 163: 1100-1102. 10.1176/appi.ajp.163.6.1100.CrossRefPubMed

63.

Miyake Y, Sasaki S, Yokoyama T, Tanaka K, Ohya Y, Fukushima W, Saito K, Ohfuji S, Kiyohara C, Hirota Y, The Osaka Maternal and Child Health Study Group: Risk of postpartum depression in relation to dietary fish and fat intake in Japan: the Osaka Maternal and Child Health Study. Psychol Med. 2006, 36: 1727-1735. 10.1017/S0033291706008701.CrossRefPubMed

64.

Peet M, Horrobin DF: A dose-ranging study of the effects of ethyl-eicosapentaenoate in patients with ongoing depression despite apparently adequate treatment with standard drugs. Arch Gen Psychiatry. 2002, 59: 913-919. 10.1001/archpsyc.59.10.913.CrossRefPubMed

65.

Nemets H, Nemets B, Apter A, Bracha Z, Belmaker RH: Omega-3 treatment of childhood depression: A controlled, double-blind pilot study. Am J Psychiatry. 2006, 163: 1098-1100. 10.1176/appi.ajp.163.6.1098.CrossRefPubMed

66.

Frangou S, Lewis M, McCrone P: Efficacy of ethyl-eicosapentaenoic acid in bipolar depression: Randomized double-blind placebo-controlled study. Br J Psychiatry. 2006, 188: 46-50. 10.1192/bjp.188.1.46.CrossRefPubMed

67.

Peet M, Stokes C: Omega-3 fatty acids in the treatment of psychiatric disorders. Drugs. 2005, 65: 1051-1059. 10.2165/00003495-200565080-00002.CrossRefPubMed

68.

Freeman MP, Hibbeln JR, Wisner KL, Brumbach BH, Watchman M, Gelenberg AJ: Randomized dose-ranging pilot trial of omega-3 fatty acids for postpartum depression. Acta Psychiatr Scand. 2006, 113: 31-35. 10.1111/j.1600-0447.2005.00660.x.CrossRefPubMed

69.

Akabas SR, Deckelbaum RJ: Summary of a workshop on n-3 fatty acids: current status of recommendations and future directions. Am J Clin Nutr. 2006, 83 (6 Suppl): 1536S-1538S.PubMed

70.

Hibbeln JR: Seafood consumption, the DHA content of mothers' milk and prevalence rates of postpartum depression: A cross-national, ecological analysis. J Affect Disord. 2002, 69: 15-29. 10.1016/S0165-0327(01)00374-3.CrossRefPubMed

71.

Cheruku SR, Montgomery-Downs HE, Farkas SL, Thoman EB, Lammi-Keefe CJ: Higher maternal plasma docosahexaenoic acid during pregnancy is associated with more mature neonatal sleep-state patterning. Am J Clin Nutr. 2002, 76: 608-613.PubMed

72.

Balch P: Prescription for Herbal Healing. 2002, New York: Avery

73.

O'Brien SM, Scott LV, Dinan TG: Antidepressant therapy and C-reactive protein levels. Br J Psychiatry. 2006, 188: 449-452. 10.1192/bjp.bp.105.011015.CrossRefPubMed

74.

Kiecolt-Glaser JK, Loving TJ, Stowell JR, Malarkey WB, Lemeshow S, Dickinson SL, Glaser R: Hostile marital interactions, proinflammatory cytokine production, and wound healing. Arch Gen Psychiatry. 2005, 62: 1377-1384. 10.1001/archpsyc.62.12.1377.CrossRefPubMed

75.

Suarez EC, Lewis JG, Krishnan RR, Young KH: Enhanced expression of cytokines and chemokines by blood monocytes to in vitro lipopolysaccharide stimulation are associated with hostility and severity of depressive symptoms in healthy women. Psychoneuroendocrinology. 2004, 29: 1119-1128. 10.1016/j.psyneuen.2004.01.002.CrossRefPubMed

76.

Rupke SJ, Blecke D, Renfrow M: Cognitive therapy for depression. Am Fam Physician. 2006, 73: 83-86.PubMed

Title: A new paradigm for depression in new mothers: the central role of inflammation and how breastfeeding and anti-inflammatory treatments protect maternal mental health
Author: Kathleen Kendall-Tackett
Publication date: 01-03-2007
Publisher: BioMed Central
Published in: International Breastfeeding Journal / Issue 1/2007
Electronic ISSN: 1746-4358
DOI: https://doi.org/10.1186/1746-4358-2-6

At a glance: The STEP trials

Springer Medicine

A new paradigm for depression in new mothers: the central role of inflammation and how breastfeeding and anti-inflammatory treatments protect maternal mental health

Abstract

Background

Discussion

Conclusion

At a glance: The STEP trials

Springer Medicine

Abstract

Background

Discussion

Conclusion

Please log in to get access to this content

Other articles of this Issue 1/2007

A family practice breastfeeding education pilot program: an observational, descriptive study

Short-term prolactin administration causes expressible galactorrhea but does not affect bone turnover: pilot data for a new lactation agent

Early lactation performance in primiparous and multiparous women in relation to different maternity home practices. A randomised trial in St. Petersburg

Infant feeding, poverty and human development

Overabundant milk supply: an alternative way to intervene by full drainage and block feeding

Evaluation of a peer counselling programme to sustain breastfeeding practice in Hong Kong